0 CHECKOUT

PRODUCT FILTERS

REGION

94
43
33
32
32

COUNTRY

13
13
8
8
8

CATEGORIES

  • 105
  • 72
  • 39
  • 38
  • 37
  • 30
  • 27
  • 25
  • 19
  • 16
  • 14
  • 13
  • 12
  • 9
  • 9
  • 7
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

133
202
229
452

PUBLISHED

4
25
75
452

PRODUCT TYPE

263
108
53
14
6
5
3

Search for: "Antiviral Drugs - DUPLICATE"

Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market

GBI Research, the leading business intelligence provider, has released its latest research “Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics...

Published:  April 2012
Price:  From

Competitor Analysis: Antiviral Antibodies

This report, as of July 2008, provides a competitor analysis in the development pipeline of novel antibodies against viral infections such as hepatitis C virus (HCV), hepatitis B virus, SARS coronavirus,...

Published:  July 2008
Price:  From

Antiviral Drug Strategies, Volume 50. Methods and Principles in Medicinal Chemistry

By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics...

Published:  April 2011
Price: 

Antiviral Drugs. From Basic Discovery Through Clinical Trials

This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral...

Published:  July 2011
Price: 

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

Published:  January 2016
Price:  From

Advances in Antiviral Drug Design, Vol 5

Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses...

Published:  July 2007
Price: 

Global Infectious Disease Treatment Market 2014-2018

About Infectious Disease Treatment Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one...

Published:  August 2014
Price:  From

Advances in Antiviral Drug Design, Volume 4, Vol 4

The fourth volume of Advances in Antiviral Drug Design is keeping up with the recent progress made in the broad field of antiviral drug research and encompasses six specific directions that have opened...

Published:  December 2003
Price: 

Advances in Antiviral Drug Design, Volume 3, Vol 3

Volume 3 of Advances in Antiviral Drug Design is keeping up with the recent progress made in the field of antiviral drug research and highlights five specific directions that have opened new avenues...

Published:  November 1999
Price: 

Injectable Drug Delivery Global Market Analysis - Forecast (2014-2020)

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique...

Published:  July 2015
Price:  From

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)

This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials...

Published:  February 2012
Price:  From

The World Market for Anti-infectives Volume III: The World Market for Antiviral Medications

This report analyzes the world markets for human antiviral medications, focusing on the current market for and the development of drugs that are used to directly combat and treat viruses viral infections....

Published:  April 2003
Price:  From

Branded Injectables to 2020

Advances in coatings and device designs have led to prefilled biologicals in patient-friendly drug-device combination products that were not possible just a few years ago Prefilled drug cartridges have...

Published:  May 2014
Price:  From

Generic Drug Opportunity Assessment - Etravirine (Intelence)

This branded drug represents an attractive opportunity for generic drug companies The Brand Intelence (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency...

Published:  January 2014
Price:  From

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth Summary GBI Research in its present report ”Generics...

Published:  June 2012
Price:  From

Generic Drug Opportunity Assessment - Boceprevir (Victrelis)

Boceprevir is a direct acting antiviral drug against the hepatitis C (HCV) virus It is an inhibitor (protease inhibitor) of the HCV non-structural protein 3 (NS3) serine protease Protease inhibitors...

Published:  January 2014
Price:  From

Drug Injection Devices to 2022

The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug...

Published:  May 2015
Price: 

Anti-infectious Disease Drugs Markets in China

China's demand for Anti-infectious Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high...

Published:  July 2015
Price:  From

Self-injectable Specialty Drugs to 2022

Increases in life expectancy are expected to result in a growing number of patients diagnosed with chronic conditions. To counteract the financial and logistical implications of this trend, pressure...

Published:  September 2015
Price: 

Sustained Release Injectables to 2022

The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent...

Published:  January 2015
Price:  From
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Bugaboo International B.V.
  • Svenska Cellulosa Aktiebolaget SCA
  • Kimberly-Clark Corporation
  • Medela